⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DMRA News
Damora Therapeutics, Inc. Common Stock
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DMRA
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
DMRA
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
globenewswire.com
DMRA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DMRA
International Self-Care Day: Dimora Medical Highlights Wound Care as an Essential Part of Everyday Self-Care
prnewswire.com
DMRA
Form 8-K
sec.gov
DMRA
Damora Announces Redomestication from Delaware to Cayman Islands
globenewswire.com
DMRA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DMRA
Form 8-K
sec.gov
DMRA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DMRA